Latest Exploration News

Cadoux Limited has made significant progress in developing its high purity alumina and rare earths projects, advancing engineering design, customer engagement, and funding strategies during the June 2025 quarter.

Tempest Minerals reports a maiden inferred mineral resource of 63.5 million tonnes at 30.6% iron for its Remorse Deposit, alongside promising gold anomalies at its Sanity Target and a successful $1.87 million capital raise.

Fin Resources Limited is gearing up for a key geophysical survey at its McKenzie Springs copper-nickel-cobalt project while securing $445,000 in funding through convertible notes amid challenging market conditions.

EQ Resources delivered a robust Q4 FY2025 with strong tungsten output from its Spanish and Australian operations, bolstered by strategic capital raises and key plant enhancements.

Red Metal Limited’s June 2025 Quarterly Report highlights significant metallurgical advances at its Sybella rare earth project and accelerated drilling programs across copper-gold and gold targets, supported by government grants and resource upgrades.

Freehill Mining reported a transitional quarter marked by a dip in sales due to project cycles but offset by strategic site acquisitions and a successful capital raise. The company is poised for growth with new processing sites and promising magnetite test results.

Freehill Mining Ltd reported a challenging quarter ending June 2025 with net cash outflows from operations, but anticipates improved revenues from its Chilean operations as it ramps up activity.

Auric Mining wraps up its final gold processing campaign at Jeffreys Find with strong cash flow, while advancing mining and acquisitions at Munda and Higginsville to fuel growth.

Ramelius Resources has completed its acquisition of Spartan Resources, issuing new shares and cash to Spartan shareholders and reshaping its board as it integrates the Dalgaranga asset.

Ramelius Resources has finalized its acquisition of Spartan Resources, issuing new shares and cash to Spartan shareholders while expanding its board and asset portfolio. This move aims to accelerate Ramelius' growth toward becoming a half-million ounce gold producer within five years.

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.

Pilot Energy has secured a $1.5 million debt note to bolster cash flow ahead of a substantial $4.5 million Petroleum Resource Rent Tax refund linked to the decommissioning of the Cliff Head Oil Field.